Know Cancer

forgot password

Quality of Life of Gynecologic Cancer Survivors

Not Enrolling
Endometrial Cancer, Ovarian Cancer

Thank you

Trial Information

Quality of Life of Gynecologic Cancer Survivors


- Describe the significant quality of life (QOL) concerns and long term survivorship
issues of women diagnosed and treated for early stage ovarian and endometrial cancer
five or more years ago.

- Identify mechanisms which contribute to a gynecologic cancer survivorship model through
comparison and prediction of high versus low QOL associated with long term adjustment
and survivorship. Examine social support, coping efforts, self-efficacy, meaning
associated with survivorship, performance status, and age at diagnosis as potential

- Identify and compare factors that predict high versus low QOL for women with early
stage endometrial cancer completing participation in GOG-99 clinical trial. Conduct
exploratory analysis examining long term QOL concerns of survivors randomized to
surgery arm with or without radiotherapy.

OUTLINE: Patients complete one telephone interview with a professional female interviewer.
The interview lasts approximately 60 minutes and is audiotaped.

PROJECTED ACCRUAL: A total of 197 early stage endometrial cancer survivors and 114 early
stage ovarian cancer survivors will be accrued for this study within 2 years.

Inclusion Criteria


- Histologically confirmed early stage ovarian and endometrial cancer survivors treated
and diagnosed five or more years ago

- Patients completing treatment in GOG-95 or GOG-99 protocols at least 5 years ago with
no recurrence of disease

- Patients with secondary malignancy or under treatment for other medical conditions
are eligible



- Not specified

Performance status:

- Not specified

Life expectancy:

- Not specified


- Not specified


- Not specified


- Not specified


- Must be capable of completing telephone interview in English


Biologic therapy:

- See Disease Characteristics


- See Disease Characteristics

Endocrine therapy:

- See Disease Characteristics


- See Disease Characteristics


- See Disease Characteristics

Type of Study:


Study Design:


Principal Investigator

Lari B. Wenzel, PhD

Investigator Role:

Study Chair

Investigator Affiliation:

Chao Family Comprehensive Cancer Center


United States: Federal Government

Study ID:




Start Date:

April 1999

Completion Date:

Related Keywords:

  • Endometrial Cancer
  • Ovarian Cancer
  • stage I ovarian epithelial cancer
  • stage II ovarian epithelial cancer
  • stage I endometrial carcinoma
  • stage II endometrial carcinoma
  • Endometrial Neoplasms
  • Ovarian Neoplasms
  • Adenoma



Fred Hutchinson Cancer Research Center Seattle, Washington  98109
Memorial Sloan-Kettering Cancer Center New York, New York  10021
University of Texas - MD Anderson Cancer Center Houston, Texas  77030-4009
Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California  90095-1781
Chao Family Comprehensive Cancer Center Orange, California  92868
University of Colorado Cancer Center Denver, Colorado  80262
Walter Reed Army Medical Center Washington, District of Columbia  20307-5000
H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida  33612
Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois  60612
University of Chicago Cancer Research Center Chicago, Illinois  60637
Indiana University Cancer Center Indianapolis, Indiana  46202-5265
Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky  40536-0084
University of Massachusetts Memorial Medical Center Worcester, Massachusetts  01655
University of Mississippi Medical Center Jackson, Mississippi  39216-4505
Washington University School of Medicine Saint Louis, Missouri  63110
Cooper Hospital/University Medical Center Camden, New Jersey  08103
Cancer Center of Albany Medical Center Albany, New York  12208
State University of New York Health Science Center at Brooklyn Brooklyn, New York  11203
University of Rochester Cancer Center Rochester, New York  14642
State University of New York Health Sciences Center - Stony Brook Stony Brook, New York  11790-7775
Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina  27599-7295
Duke Comprehensive Cancer Center Durham, North Carolina  27710
Barrett Cancer Center, The University Hospital Cincinnati, Ohio  45219
Ireland Cancer Center Cleveland, Ohio  44106-5065
Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio  43210
University of Oklahoma College of Medicine Oklahoma City, Oklahoma  73190
Abington Memorial Hospital Abington, Pennsylvania  19001
Milton S. Hershey Medical Center Hershey, Pennsylvania  17033
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania  19107
University of Pennsylvania Cancer Center Philadelphia, Pennsylvania  19104
Fox Chase Cancer Center Philadelphia, Pennsylvania  19111
Medical University of South Carolina Charleston, South Carolina  29425-0721
Simmons Cancer Center - Dallas Dallas, Texas  75235-9154
Tacoma General Hospital Tacoma, Washington  98405
New England Medical Center Hospital Boston, Massachusetts  02111
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama  35294-3300
Community Hospital of Los Gatos Los Gatos, California  95032
Holden Comprehensive Cancer Center at The University of Iowa Iowa City, Iowa  52242-1009
Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina  27157-1082
Brookview Research, Inc. Nashville, Tennessee  37203
CCOP - Montana Cancer Consortium Billings, Montana  59101
Cleveland Clinic Taussig Cancer Center Cleveland, Ohio  44195
Schneider Children's Hospital at North Shore Manhasset, New York  11030